Agile Growth Corp. (NASDAQ:AGGRU – Get Rating) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 23,600 shares, a decrease of 25.6% from the October 15th total of 31,700 shares. Currently, 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 3,700 shares, the days-to-cover ratio is currently 6.4 days.
Agile Growth Stock Performance
NASDAQ AGGRU opened at $9.97 on Friday. Agile Growth has a twelve month low of $9.79 and a twelve month high of $10.13. The stock has a fifty day simple moving average of $9.93 and a 200-day simple moving average of $9.87.
Get Agile Growth alerts:Hedge Funds Weigh In On Agile Growth
Hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. acquired a new position in Agile Growth during the 1st quarter worth about $1,556,000. Spartan Fund Management Inc. acquired a new position in Agile Growth during the 1st quarter worth about $1,537,000. Ancora Advisors LLC acquired a new position in Agile Growth during the 1st quarter worth about $914,000. Walleye Capital LLC acquired a new position in Agile Growth during the 2nd quarter worth about $198,000. Finally, Walleye Trading LLC acquired a new position in Agile Growth during the 2nd quarter worth about $112,000.
Agile Growth Company Profile
(Get Rating)Agile Growth Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire businesses in the technology industry, including infrastructure, and horizontal and vertical enterprise application software; healthcare IT; financial technology; robotics/automation; and education technology, as well as additional software and technology segments.
See Also
- Get a free copy of the StockNews.com research report on Agile Growth (AGGRU)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for Agile Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agile Growth and related companies with MarketBeat.com's FREE daily email newsletter.